Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin

Frontiers in Immunology(2020)10.3389/fimmu.2020.00431Source: DataRank Database

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.69)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Marta Baranowska-Hustad,Justin R. Abadejos ORCID,Tanya R. Blane ORCID,John R. Teijaro ORCID,David Nemazee ORCID

Live enrichment

PubMed:32269566 PMC:PMC7112135 OpenAlex:https://openalex.org/W3012985296

NIAID NIH HHS

Grant: R01 AI132317

NIAID NIH HHS

Grant: R37 AI059714

NIAID NIH HHS

Grant: R01 AI059714

Norges Forskningsråd

Stiftelsen Kristian Gerhard Jebsen

FWCI

0.69

Citation Percentile

0.7%

Citation Trend

2020

2023

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00431/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00431/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.00431/full

journalhttps://doi.org/10.3389/fimmu.2020.00431

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32269566

Fields of Study

Influenza Virus Research StudiesImmune Cell Function and InteractionImmunotherapy and Immune Responses

MeSH Terms

AnimalsAntibody FormationHistocompatibility Antigens Class IICross ReactionsFemaleHLA AntigensHumansInfluenza, HumanInfluenza VaccinesMice, Inbred BALB COrthomyxoviridae InfectionsVaccinationHemagglutinin Glycoproteins, Influenza VirusVaccines, DNAMiceInfluenza A Virus, H1N1 SubtypeDisease ResistanceInfluenza A Virus, H7N9 Subtype

Keywords

Hemagglutinin (influenza)ImmunogenicityVirologyVaccinationEpitopeAntigenic driftBiologyAntibodyDNA vaccinationAntigenInfluenza A virusInfluenza vaccinePopulationImmunologyMedicineImmunizationVirusDNA vaccineHemagglutinin (Ha)MhciiVh1-69Apc-targeted AntigenStem Domain

Sustainable Development Goals

SDG 0: Good health and well-being